Skip to Content
Looking to save on your medications?  Find out how 

Adakveo

Generic name: crizanlizumab-tmca

What is Adakveo?

Adakveo is used:

  • in people 16 years of age and older who have sickle cell disease
  • to help reduce how often certain episodes (crises) happen.

It is not known if Adakveo is safe and effective in children under 16 years of age.

What is the most important information I should know about Adakveo?

Adakveo may cause serious side effects, including:
Infusion reactions. Infusion reactions may happen within 24 hours of receiving an infusion of Adakveo. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infusion reaction:

  • fever
  • chills or shivering
  • nausea
  • vomiting
  • tiredness
  • dizziness
  • sweating
  • hives
  • itching
  • shortness of breath or wheezing

Your healthcare provider may monitor you for signs and symptoms of infusion reactions.
Adakveo may interfere with a certain blood test.
Tell your healthcare providers that you are receiving Adakveo before having any blood tests. Adakveo may interfere with a laboratory test to measure your platelet counts.
See "What are possible side effects of Adakveo?" for more information about side effects.

What should I tell my healthcare provider before using Adakveo?

Before receiving Adakveo, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. It is not known if Adakveo may harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Adakveo passes into your breast milk. You and your healthcare provider should decide the best way to feed your baby during treatment with Adakveo.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the counter medicines, vitamins, and herbal supplements.

How should I use Adakveo?

  • Your healthcare provider will give you Adakveo as an infusion into your vein through an intravenous (IV) line over 30 minutes.
  • You will receive your first infusion, and then a second infusion 2 weeks later. After that, you will receive an infusion every 4 weeks.
  • Your healthcare provider may also prescribe other treatments for you to take during treatment with Adakveo.
  • Do not stop receiving Adakveo unless your healthcare provider tells you to.
  • If you miss an appointment for infusion, call your healthcare provider as soon as possible to reschedule.

What are the possible side effects of Adakveo?

Adakveo may cause serious side effects. See "What is the most important information I should know about Adakveo?"

The most common side effects of Adakveo include:

  • nausea
  • back pain
  • joint pain
  • fever

These are not all of the possible side effects of Adakveo. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of Adakveo

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information guide. You can ask your healthcare provider or pharmacist for more information about Adakveo.

How should I store Adakveo?

  • Store and transport refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
  • Do not shake. Do not freeze.

What are the ingredients in Adakveo?

Active ingredient: crizanlizumab-tmca
Inactive ingredients: citric acid, polysorbate 80, sodium citrate, and water for injection

For more information, go to www.adakveo.com or call 1-877-ADAKVE-0 (1-877-232-5830).

Source: National Library of Medicine. Last updated November 30, 2019.